Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks. - Wikidata - wikimedia - TriplyDB

Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.

Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.

http://www.wikidata.org/entity/Q37094822

about

High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk The role of the lymphatic system in cholesterol transport Molecular mechanisms of cellular cholesterol efflux Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?AIBP: A Novel Molecule at the Interface of Cholesterol Transport, Angiogenesis, and Atherosclerosis Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein High-Density Lipoprotein Processing and Premature Cardiovascular Disease No effect of acute exposure to coarse particulate matter air pollution in a rural location on high-density lipoprotein function Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.High-density lipoprotein metabolism, composition, function, and deficiency.Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.Cholesterol and lipoprotein metabolism: Early Career Committee contribution Anti-psoriatic therapy recovers high-density lipoprotein composition and function.Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.HDL size is more accurate than HDL cholesterol to predict carotid subclinical atherosclerosis in individuals classified as low cardiovascular risk.Dysfunctional high-density lipoproteins in children with chronic kidney disease HDL cholesterol efflux capacity and incident cardiovascular events.Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens.Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome.High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity.Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis.Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study New Insights into the High-Density Lipoprotein Dilemma HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo.The effects of apolipoprotein B depletion on HDL subspecies composition and function A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.Regulation of signal transduction by HDL.

P2860

Q26775420-300FE2ED-2314-4708-8BF3-0EF6233C8B4A Q26782973-BD94A4DC-02DC-4A43-BE57-38029A2FD565 Q27021139-1AE638D9-5721-480E-AC3F-12B7CBDE812E Q28080768-4F064D04-168E-4731-9B78-CA2A845E3B63 Q28083058-FDD4F888-2085-46DF-9DF4-AB39F79E0DCC Q28083619-1E953E40-7487-4851-8B7F-441752041D8D Q28085143-7A82310B-B40E-49F5-AD58-D3F19763E7F7 Q28394963-CC94960C-A219-4424-B322-490EADC2099B Q30251632-B5E63AAF-7108-41F6-9955-47534CD43AF7 Q30251918-FC762C2B-39FE-40F2-8AE0-5775B1C2F579 Q33582205-522797CA-0A84-4488-A817-BFCF39AB3DE5 Q33675617-3473A514-D966-454E-AC9B-23BA9BFED2D1 Q33848028-9F2F05BC-5782-4C20-8AFC-FEEEEA6A3975 Q33940012-923561CF-9D90-4D5E-B882-FCDF4A279A55 Q34076117-D7D3E381-5D7F-4D18-83A0-4893497AD528 Q34081210-0D02C0A2-2B19-4175-B544-A623CDB1EE26 Q34259215-FA061D0D-FFB5-430C-A84B-F409EC656F52 Q34565234-2F5DC218-6207-40DE-AB67-3EDED71A0F27 Q34627415-EC2A3755-8505-47FF-9BD3-DCE3E59EC70C Q34779002-0FADA2FD-C819-4395-ABC3-4524F81F763C Q35021594-43431555-BF64-4A0A-AE02-BE5CE6ABFD4F Q35036648-165FEEC4-AB3E-4210-88F5-D8DFB5FB70CF Q35120931-50FCFDC3-DDDE-4CA0-84FD-9FB61E43DE9A Q35120941-30C25AC7-2C02-41F9-B8F4-6166D87E93F4 Q35686360-B1EA12DD-5E37-4A73-A255-4F214ECFFA35 Q35802117-B73F8DAB-DC66-4A54-AAC8-4B920F22A435 Q35886286-63A0E6BF-555A-4043-BDC8-340B994C6703 Q36030580-63D2CAC1-56D9-49CA-BD83-38B568BB6781 Q36093194-7B6C4900-94EA-4DC2-8002-0B85986E18E3 Q36157875-7B335C8D-41AD-4B40-A1A0-A33F40383571 Q36282932-73632804-2ADF-454A-A3A9-AA1AEAFF6084 Q36287533-28E65A14-1BFD-478F-A697-6F2C50043AAF Q36450075-4817A855-485E-4683-BDF1-1AE8675D5C99 Q36514875-A1C00963-F62F-4186-8E45-4874512EEC94 Q36720650-4041A614-874B-41DC-A5B0-1824D35EFE59 Q36731786-A2D59231-8B1E-4AE1-8EE1-39F1736F5FE6 Q36744820-24993657-83C7-442B-852C-295B25E3D30D Q36782847-10705ACF-0C89-4F1C-BB7C-BB3BAEF38D9A Q36988873-1F6907AE-FBFC-4BB3-B8DF-916B689A613E Q37076473-A89D7F6A-3CE9-43C8-AF53-2C08D86040DC

P2860

Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.

http://www.wikidata.org/entity/Q37094822

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 March 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Paradoxical association of enh ...... incident cardiovascular risks.

@en

Paradoxical association of enh ...... incident cardiovascular risks.

@nl

type

label

Paradoxical association of enh ...... incident cardiovascular risks.

@en

Paradoxical association of enh ...... incident cardiovascular risks.

@nl

prefLabel

Paradoxical association of enh ...... incident cardiovascular risks.

@en

Paradoxical association of enh ...... incident cardiovascular risks.

@nl

P1433

Q37094822-8D8F73EF-6FA3-4033-B489-40492DA7F79A

P1476

Q37094822-29F7B4CE-9D90-41A5-9135-904A01780B53

P2093

Q37094822-19CA95AD-CA89-4DA1-811C-7EA50D206395

Q37094822-299D0176-D5E2-4AF9-916A-3BF5879E26B4

Q37094822-39DBCB45-96C6-45EA-9579-93BDF7F15E3A

Q37094822-3C7C6E45-1539-40D6-9180-D85AD164A97E

Q37094822-43C772AD-F4AF-481C-ADF5-FEC0ACCF57F3

Q37094822-50A439F7-E3F8-4343-8BA4-75D2A36FF07D

Q37094822-7106A798-FFD8-4D70-83AB-9CCC0B9357A5

Q37094822-98B3CD9F-27D4-42E6-B862-0F25480FA607

Q37094822-C7A8F202-3077-4805-AB36-1581AB883C95

Q37094822-FD6DAB29-ACC6-4C44-AA0C-6CAAD96778DE

P2860

Q37094822-0BCCF96D-E185-4B01-B3B4-F0218CD9DDC6

Q37094822-151D27B1-D57D-4AB4-9055-A1A3F5C86E0F

Q37094822-1B688812-4575-43C1-B186-C61DB1A10A80

Q37094822-2132AC04-637C-40B9-9845-04968D0D01BD

Q37094822-2E458C1B-3C34-424A-B466-FA28FB1E5CA0

Q37094822-2EB95933-5AB7-4050-9615-CAE8296E0EE5

Q37094822-2F8B3C37-21D5-4CCF-A2E2-630D06C539A5

Q37094822-349C5CF6-EF72-4E2B-9426-3D7D34C9B120

Q37094822-3B2056CF-213F-49C2-B5CF-5BCB60D022CA

Q37094822-49D9B919-44AE-423F-A83F-81054C3FE6F9

P304

Q37094822-0A0106E2-5FF1-492F-946B-CBA56A6BEFF1

P31

Q37094822-7DE4F1C6-2621-4792-BA92-6D52A502D3D4

P356

Q37094822-6B51F051-5177-43D1-8B7A-8899D293AC2A

P407

Q37094822-B804B6FA-3CE0-449E-8B6C-F5349C61BA60

P433

Q37094822-50FC2D18-9F83-4DDF-B0B0-DA1B0E606599

P478

Q37094822-19A5691E-C755-48AF-A04F-DC3D8CFF782A

P50

Q37094822-9350714F-FC7E-43F2-BC43-E04601A1F3E8

Q37094822-EAAC8171-EC58-423A-99C1-59C1AAC46556

P577

Q37094822-CF9D5F5C-FCDD-45FA-8040-C7B9E96B6268

P698

Q37094822-4151E47E-CB2E-471D-92B8-F80B5E4D1EAA

P921

Q37094822-0B3A288F-5670-4798-B5E3-63AC87D166E5

P932

Q37094822-32D83ACD-F5AC-4E09-8D02-74999363789B

P356

ATVBAHA.113.301373

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Paradoxical association of enh ...... incident cardiovascular risks.

@en

P2093

David Schmitt

http://www.w3.org/2001/XMLSchema#string

Joseph A Didonato

http://www.w3.org/2001/XMLSchema#string

Marian K Mosior

http://www.w3.org/2001/XMLSchema#string

Stanley L Hazen

http://www.w3.org/2001/XMLSchema#string

Vivian Gao

http://www.w3.org/2001/XMLSchema#string

Wai Hong Wilson Tang

http://www.w3.org/2001/XMLSchema#string

William Matter

http://www.w3.org/2001/XMLSchema#string

Xin-Min Li

http://www.w3.org/2001/XMLSchema#string

Ying Huang

http://www.w3.org/2001/XMLSchema#string

Yuping Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Effect of torcetrapib on the progression of coronary atherosclerosis

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr.

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Comprehensive peroxidase-based hematologic profiling for the prediction of 1-year myocardial infarction and death.

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

P304

1696-1705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.113.301373

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Edward A Fisher

Jonathan D Smith

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23520163

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3743250

http://www.w3.org/2001/XMLSchema#string